Iome Bio

Description: Iome Bio develops microbiome-based immuno-oncology drugs to enhance cancer treatment efficacy using proprietary insights and monoclonal antibodies.

Country: France

Based in: Colmar

Founded: 2020

Funding Stage: Seed

Tags: ['Biotechnology', 'Health Care', 'Life Science']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.